Not yet recruiting NCT06474949
Local Anesthetic for Plateau Fractures
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Bupivacaine injection, Saline.
- Who it may be relevant to
- Registry conditions: Tibial Plateau Fractures. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
Subjects may receive an injection at the end of the surgery to fix their broken leg that may reduce their pain and hospital stay
Detailed description
Subjects will be randomized to bupivicaine or saline injection in the joint at the end of Open Reduction Internal Fixation of the tibial plateau fracture
Interventions
- Drug Bupivacaine injection
Injection at end of Open Reduction Internal Fixation - Other Saline
Injection at end of Open Reduction Internal Fixation
Primary outcome measures
- Pain in the knee visual analogue scale 11 point scale 0(no pain) -10 (worst pain) [Time frame: From date of hospitalization to end of follow-up at 6 months]
Secondary outcome measures (1)
- Length of stay for hospitalization [Time frame: From date of hospitalization up to one month post surgery]
Eligibility criteria
Inclusion criteria
- Age >=18 year ,
- tibial plateau fracture undergoing Open Reduction and fixation"
Exclusion:
- allergy to bupivacaine
- Prolonged external fixator use
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Double blind
- Primary purpose
- Prevention
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT06474949 · STUDY00017105